Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers

NCT00020878 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: celecoxib

Sponsor

Jonsson Comprehensive Cancer Center